Lets use a figure from te study to understand
its also about making lasting lifestyle changes
Why "highest dose = best" isn't always true The SURMOUNT-1 averages favor 15 mg as the most weight-loss-effective dose
FDA: Compounded Semaglutide Associated with Adverse Events Due to Overdosing By Dave Quaile, MD /alert Contributor August 13, 2024 The FDA has issued a warning to patients and healthcare providers about adverse events associated with compounded injectable semaglutide, highlighting risks due to variability in packaging, concentrations, and dosing
#GLP1 #groceryindustry #foodretail To view or add a comment, sign in More Relevant Posts This week we hosted our Cirkle GLP-1s panel event alongside the IGD (Institute of Grocery Distribution) and the topic continues to fascinate me
It includes GLP-1 medication management, nutrition guidance, and ongoing follow-up